Cytokine storm

Pro-inflammatory Cytokines Released by Macrophages in Sepsis:

1. Tumor Necrosis Factor-α (TNF-α)
   • One of the earliest cytokines released.
   • Potent activator of endothelial cells → increases vascular permeability, adhesion molecule expression.
   • Drives fever, hypotension, and septic shock.
2. Interleukin-1β (IL-1β)
   • Promotes fever (via hypothalamic PGE₂ stimulation).
   • Enhances expression of adhesion molecules.
   • Amplifies leukocyte recruitment.
3. Interleukin-6 (IL-6)
   • Induces acute-phase protein synthesis in the liver (CRP, fibrinogen).
   • Contributes to systemic inflammation, fever, and vascular leakage.
4. Interleukin-8 (IL-8 / CXCL8)
   • Major chemokine for neutrophil recruitment and activation.
   • Increases oxidative burst and degranulation.
5. High Mobility Group Box 1 (HMGB1)
   • Released later in sepsis.
   • Acts as a damage-associated molecular pattern (DAMP).
   • Sustains late systemic inflammation.
6. Other mediators (released in smaller amounts but important):
   • MCP-1 (CCL2): recruits monocytes.
   • MIP-1α/β: chemotactic for immune cells.
   • GM-CSF: enhances leukocyte survival and function.

Clinical Relevance

• Excessive cytokine release → systemic inflammatory response syndrome (SIRS).
• Leads to vasodilation, capillary leakage, hypotension, disseminated intravascular coagulation (DIC), and multi-organ dysfunction.
• Therapies targeting TNF-α and IL-1 have been explored, but with limited success due to the complex balance between pro- and anti-inflammatory pathways in sepsis.

Most common pro-inflammatory cytokines released by macrophages in sepsis

[A] TNF-α

[B] IL-8

[C] Interleukin-6

[D] MIP-1α

Cytokine which is first to be released in response to a pathogen in sepsis

[A] TNF-α

[B] IL-8

[C] Interleukin-6

[D] MIP-1α

Most common pro-inflammatory cytokines released by macrophages in sepsis are tumor necrosis factor (TNF)- α and interleukin (IL) -1β

Cytokine Storm

📌 Definition

A cytokine storm is an excessive, uncontrolled release of pro-inflammatory cytokines by immune cells (macrophages, dendritic cells, T-cells, NK cells, etc.), leading to systemic inflammation, vascular leakage, shock, and multi-organ failure.

It represents a hyper-activation of the immune system, often more harmful than the triggering infection itself.

🚨 Key Features of Cytokine Storm

• Rapid and excessive production of pro-inflammatory cytokines.
• Loss of balance between pro- and anti-inflammatory responses.
• Results in endothelial dysfunction, capillary leak, hypotension, and tissue injury.
• Final outcome → multi-organ dysfunction if unchecked.

🧪 Major Cytokines Involved

⚡ Clinical Conditions Associated with Cytokine Storm

• Sepsis
• COVID-19 severe pneumonia / ARDS
• CAR-T cell therapy (immunotherapy)
• Hemophagocytic lymphohistiocytosis (HLH)
• Severe influenza (H5N1, H1N1)
• Graft-versus-host disease (GVHD)

🏥 Clinical Manifestations

• High fever
• Hypotension & shock
• Dyspnea, ARDS (acute respiratory distress syndrome)
• Coagulopathy (↑ D-dimer, DIC)
• Multi-organ failure (kidney, liver, CNS involvement)

💉 Management Strategies

• Supportive care → fluids, vasopressors, oxygen/ventilation.
• Anti-cytokine therapy (in selected conditions):
  • IL-6 inhibitors (Tocilizumab, Sarilumab)
  • IL-1 blockers (Anakinra)
  • JAK inhibitors (Ruxolitinib, Baricitinib)
• Corticosteroids → dampen hyperinflammation (e.g., dexamethasone in COVID-19).

🧾 20 Important Facts about Cytokine Storm

❓ Quick Review: 10 Short Q&A on Cytokine Storm

📊 Comparison: Cytokine Storm vs Normal Immune Response

Cytokine storm, cytokine release syndrome, CRS, hyperinflammation, pro-inflammatory cytokines, sepsis cytokine storm, COVID-19 cytokine storm, CAR-T therapy complications, Hemophagocytic lymphohistiocytosis (HLH), TNF-alpha, IL-1β, IL-6, IL-8, IFN-γ, HMGB1, IL-10, acute respiratory distress syndrome (ARDS), distributive shock, hyperferritinemia, C-reactive protein (CRP), multi-organ dysfunction, immune dysregulation, cytokine storm treatment, tocilizumab, dexamethasone, JAK inhibitors, Ruxolitinib, systemic inflammatory response, SIRS, macrophage activation, endothelial dysfunction, vascular leakage.

📊 Comparison: Cytokine Storm vs Sepsis